BackgroundsA large number of studies have investigated the effect of early menopause on cardiovascular disease (CVD) outcomes and the relationship between the levels of lipid profile and primary ovarian insufficiency (POI). However, the results are inconsistent. The aim of this meta-analysis was to assess whether the levels of total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL) and low density lipoprotein (LDL) changed in women with POI relative to healthy controls.MethodsTo identify eligible studies, references published prior to December 2021 were searched in the PubMed, Embase, Cochrane Library and Web of Science databases. DerSimonian-Laird random-effects model was used to estimate the overall standard mean difference (SMD) between POI and healthy control subjects. Subgroup analysis and sensitivity analysis were preformed, and publication bias was assessed.ResultsA total of 12 studies featuring 846 women with primary ovarian insufficiency and 959 healthy women were selected for analysis. The meta-analysis showed that the levels of TC (SMD: 0.60; 95% CI: 0.32 to 0.89; P<0.0001), TG (SMD: 0.36; 95% CI: 0.12 to 0.60; P=0.003), LDL (SMD: 0.46; 95% CI: 0.16 to 0.76; P=0.003) were significantly increased in women with POI. There was no significant change in the level of HDL (SMD: 0.25; 95% CI: -0.12 to 0.61; P=0.19). Subgroup analysis showed that the heterogeneity in this meta-analysis of the correlation between lipid profile and POI might come from by region, sample size, number of cases, mean body mass index (BMI) value of cases and mean age of cases.ConclusionsScientific evidence suggests that the lipid profile levels were altered in patients with primary ovarian insufficiency compared to healthy controls. Therefore, we recommend that early medical intervention (e.g., hormone replacement therapy) to minimize the risk of CVD morbidity and mortality associated with dyslipidemia in patients with POI.Systematic Review RegistrationPROSPERO, identifier CRD42021297088
Backgrounds: A large number of studies have investigated the effect of early menopause on osteoporosis outcomes and the relationship between the content of bone mineral density (BMD) and primary ovarian insufficiency (POI). Methods: To provide a systematic literature review and meta-analysis on BMD content among women with POI. Search strategy: We performed a systematic literature search in the databases PubMed, Embase, Cochrane Library and Web of Science databases from inception through 1 April 2022 . Selection criteria: Studies including women with POI and controls were eligible. Data collection and analysis: Two reviewers independently evaluated study eligibility. We used DerSimonian-Laird random effects model for meta-analysis. Main results: A total of 10 studies featuring 578 women with POI and 480 controls were selected. The meta-analysis showed that the BMD content of femur neck(SMD:-0.76; 95% CI: -1.20 to -0.31; P=0.0008), the BMD content of nondominating forearm (SMD:-0.67; 95% CI: -1.15 to -0.18; P=0.007) were significantly decreased in women with POI. There was no significant change in the BMD content of lumbar spine (SMD: -0.32; 95% CI: -0.74 to 0.10; P=0.14), the total hip (SMD: -0.08; 95% CI: -0.79 to 0.63; P=0.82), as well as the hip neck (SMD: -0.15; 95% CI: -0.85 to 0.56; P=0.68). Conclusions: Scientific evidence suggests that the BMD content altered in patients with primary ovarian insufficiency compared with healthy controls. Therefore, we recommend that early medical intervention (e.g., hormone replacement therapy) to minimize the risk of fracture morbidity and mortality associated with osteopenia in patients with POI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.